| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6593634
[patent_doc_number] => 20020042094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'RING finger protein zapop2'
[patent_app_type] => new
[patent_app_number] => 09/735368
[patent_app_country] => US
[patent_app_date] => 2000-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 29014
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042094.pdf
[firstpage_image] =>[orig_patent_app_number] => 09735368
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/735368 | RING finger protein zapop2 | Dec 11, 2000 | Abandoned |
Array
(
[id] => 846932
[patent_doc_number] => 07384631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-10
[patent_title] => 'Methods of diagnosis and treatment by binding p75/AIRM1'
[patent_app_type] => utility
[patent_app_number] => 10/149593
[patent_app_country] => US
[patent_app_date] => 2000-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5601
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/384/07384631.pdf
[firstpage_image] =>[orig_patent_app_number] => 10149593
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/149593 | Methods of diagnosis and treatment by binding p75/AIRM1 | Dec 10, 2000 | Issued |
Array
(
[id] => 5987305
[patent_doc_number] => 20020099009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Protein for regulating apoptosis'
[patent_app_type] => new
[patent_app_number] => 09/733167
[patent_app_country] => US
[patent_app_date] => 2000-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5267
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099009.pdf
[firstpage_image] =>[orig_patent_app_number] => 09733167
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/733167 | Mutant DEDD proteins for regulating apoptosis | Dec 7, 2000 | Issued |
Array
(
[id] => 6546706
[patent_doc_number] => 20020110912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Stable human oral cancer cell carcinoma cell line'
[patent_app_type] => new
[patent_app_number] => 09/730567
[patent_app_country] => US
[patent_app_date] => 2000-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2429
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20020110912.pdf
[firstpage_image] =>[orig_patent_app_number] => 09730567
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/730567 | Stable human oral cancer cell carcinoma cell line | Dec 6, 2000 | Issued |
Array
(
[id] => 5846072
[patent_doc_number] => 20020132977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Inhibition of P53 degradation'
[patent_app_type] => new
[patent_app_number] => 09/732384
[patent_app_country] => US
[patent_app_date] => 2000-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9163
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132977.pdf
[firstpage_image] =>[orig_patent_app_number] => 09732384
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/732384 | Inhibition of p53 degradation | Dec 6, 2000 | Issued |
Array
(
[id] => 6861593
[patent_doc_number] => 20030092601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Microcompetition and human disease'
[patent_app_type] => new
[patent_app_number] => 09/732360
[patent_app_country] => US
[patent_app_date] => 2000-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 73038
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092601.pdf
[firstpage_image] =>[orig_patent_app_number] => 09732360
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/732360 | Microcompetition and human disease | Dec 6, 2000 | Abandoned |
Array
(
[id] => 6894281
[patent_doc_number] => 20010016647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => '29 human secreted proteins'
[patent_app_type] => new
[patent_app_number] => 09/729835
[patent_app_country] => US
[patent_app_date] => 2000-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56056
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016647.pdf
[firstpage_image] =>[orig_patent_app_number] => 09729835
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/729835 | 29 human secreted proteins | Dec 5, 2000 | Abandoned |
Array
(
[id] => 7078986
[patent_doc_number] => 20010041670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-15
[patent_title] => 'Thrombospondin-binding region of histidine-rich glycoprotein and method of use'
[patent_app_type] => new
[patent_app_number] => 09/730379
[patent_app_country] => US
[patent_app_date] => 2000-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16383
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20010041670.pdf
[firstpage_image] =>[orig_patent_app_number] => 09730379
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/730379 | Thrombospondin-binding region of histidine-rich glycoprotein and method of use | Dec 4, 2000 | Abandoned |
Array
(
[id] => 6208278
[patent_doc_number] => 20020071830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'Probe'
[patent_app_type] => new
[patent_app_number] => 09/729226
[patent_app_country] => US
[patent_app_date] => 2000-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13603
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20020071830.pdf
[firstpage_image] =>[orig_patent_app_number] => 09729226
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/729226 | Probe | Dec 4, 2000 | Abandoned |
Array
(
[id] => 6534778
[patent_doc_number] => 20020137038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Intestinal proteins'
[patent_app_type] => new
[patent_app_number] => 09/729454
[patent_app_country] => US
[patent_app_date] => 2000-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 19934
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137038.pdf
[firstpage_image] =>[orig_patent_app_number] => 09729454
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/729454 | Intestinal proteins | Dec 3, 2000 | Abandoned |
| 09/600413 | Use of radiolabeled monoclonal igm in therapy for cancer and autoimmune disease | Nov 29, 2000 | Abandoned |
Array
(
[id] => 1208313
[patent_doc_number] => 06713056
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-30
[patent_title] => 'Combined preparation for the treatment of neoplasic diseases or of infectious diseases'
[patent_app_type] => B1
[patent_app_number] => 09/647529
[patent_app_country] => US
[patent_app_date] => 2000-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4135
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/713/06713056.pdf
[firstpage_image] =>[orig_patent_app_number] => 09647529
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/647529 | Combined preparation for the treatment of neoplasic diseases or of infectious diseases | Nov 28, 2000 | Issued |
Array
(
[id] => 671803
[patent_doc_number] => 07090843
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-15
[patent_title] => 'Recombinant anti-CD30 antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/724406
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 24501
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/090/07090843.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724406
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724406 | Recombinant anti-CD30 antibodies and uses thereof | Nov 27, 2000 | Issued |
| 09/724599 | METHODS FOR IDENTIFYING COMPOUNDS THAT BIND TO 27420 | Nov 27, 2000 | Abandoned |
Array
(
[id] => 1180459
[patent_doc_number] => 06737259
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-18
[patent_title] => 'Modified arginine deiminase'
[patent_app_type] => B1
[patent_app_number] => 09/723546
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 13252
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/737/06737259.pdf
[firstpage_image] =>[orig_patent_app_number] => 09723546
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/723546 | Modified arginine deiminase | Nov 27, 2000 | Issued |
| 09/717883 | Novel method of diagnosing, monitoring, staging, imaging and treating cancer | Nov 20, 2000 | Abandoned |
Array
(
[id] => 1148144
[patent_doc_number] => 06774217
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-10
[patent_title] => 'FHIT proteins and nucleic acids and methods based thereon'
[patent_app_type] => B1
[patent_app_number] => 09/717054
[patent_app_country] => US
[patent_app_date] => 2000-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 13
[patent_no_of_words] => 45007
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/774/06774217.pdf
[firstpage_image] =>[orig_patent_app_number] => 09717054
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/717054 | FHIT proteins and nucleic acids and methods based thereon | Nov 20, 2000 | Issued |
| 09/713299 | The use of mosquito salivary tachykinins to remediate unregulated cellular proliferation | Nov 15, 2000 | Abandoned |
Array
(
[id] => 803414
[patent_doc_number] => 07423118
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-09-09
[patent_title] => 'IAPS associated cell cycle proteins, compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 09/715725
[patent_app_country] => US
[patent_app_date] => 2000-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 26481
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/423/07423118.pdf
[firstpage_image] =>[orig_patent_app_number] => 09715725
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/715725 | IAPS associated cell cycle proteins, compositions and methods of use | Nov 15, 2000 | Issued |
| 09/711216 | 21910, a novel human membrane-associated guanylate kinase and uses thereof | Nov 8, 2000 | Abandoned |